Big names like
Coca-Cola (KO) UTX , Caterpillar (CAT) reporting this week and I will be buying some Nov. options in anticipation of great earnings and their exposure to foreign markets, their earned income from rest of the world should translate into big surprises in US dollars. Also noted that Pharmaceuticals were rising for the past two weeks, and performing very well. Looking into
BIIB, DNA, GILD, GENZ and particularly
Alexion Pharmaceuticals (ALXN) after initiated with Buy ratings in Oct. and price target as high as $85. As John Murphy noted in his article to his subscribers; "
AMEX Biotechnology Index (BTK) trading over its spring high. Its relative strength ratio has been rising since late August." The article also points out,
GILEAD BREAKS OUT - BIOGEN TESTS MAJOR TREND LINE, GENZYME HITS NEW 52-WEEK HIGH.
My favorite tech. stocks did not pull back (enough) so I will be watching them, but can not get in before seeing some correction in Oct. , in Nov and Dec. I will be trading them on their way up.
As for trading
GLID and
ALXN (I will be waiting for some pull-back, as both stocks hitting new 52 weeks high for the past 4 trading sessions. For
KO, UTX, CAT probably execute them in the same time frame early on Monday.
No comments:
Post a Comment